Why Is Dialysis Device And Kidney Care Provider Baxter Stock Trading Higher Today?
Portfolio Pulse from Vandana Singh
Baxter International Inc (BAX) reported Q3 revenue of $3.71 billion, beating the consensus of $3.69 billion, up 3% Y/Y. Adjusted EPS of $0.82 surpassed the consensus of $0.67 and the management guidance of $0.78-$0.80. The company's sales performance exceeded its previously announced guidance, driven by new product launches, solid demand for products, and improvement in product availability. Baxter expects Q4 FY23 sales growth from continuing operations of 1%-2% and adjusted EPS of $0.85-$0.88 versus consensus of $0.84. BAX shares are up 4.48% at $34.26.
November 02, 2023 | 6:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baxter's Q3 results exceeded expectations, driven by new product launches and solid demand. The company's positive outlook for Q4 FY23 suggests continued growth. BAX shares are up 4.48%.
Baxter's Q3 results exceeded consensus estimates, which is a positive signal for investors. The company's positive outlook for Q4 FY23 suggests that it expects to maintain this momentum, which could further boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100